Sjs Investment Consulting Inc. Neurocrine Biosciences Inc Transaction History
Sjs Investment Consulting Inc.
- $540 Million
- Q4 2024
A detailed history of Sjs Investment Consulting Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 10 shares of NBIX stock, worth $1,150. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10
Previous 6
66.67%
Holding current value
$1,150
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NBIX
# of Institutions
650Shares Held
96.2MCall Options Held
380KPut Options Held
382K-
Black Rock Inc. New York, NY14.2MShares$1.63 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.16 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$563 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$347 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$292 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...